Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalini Rapti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|July 19, 2003
Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinaseMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|August 17, 2004
Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzymeMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|February 17, 2005
Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzymeMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|June 17, 2006
Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activationMagdalini Rapti, Vera Knaüper, Gillian Murphy, et al.
The Journal of Biological Chemistry|January 22, 2004
Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognitionMeng-Huee Lee, Magdalini Rapti, Vera Knaüper, et al.
Plos One|August 27, 2015
Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer EffectsJing Xian Duan, Magdalini Rapti, Anastasia Tsigkou, et al.
Biochemical Society Transactions|January 28, 2020
Fragments: where are we now?James Osborne, Stanislava Panova, Magdalini Rapti, et al.
Oncotarget|February 11, 2017
Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibitionBingjie Jiang, Yan Zhang, Jian Liu, et al.
The Biochemical Journal|January 25, 2008
The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibitionMagdalini Rapti, Susan J Atkinson, Meng-Huee Lee, et al.
Cancer Letters|October 10, 2009
The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environmentMeng-Huee Lee, Susan Atkinson, Magdalini Rapti, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|July 19, 2003
Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinaseMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|August 17, 2004
Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzymeMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|February 17, 2005
Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzymeMeng-Huee Lee, Magdalini Rapti, Gillian Murphy
The Journal of Biological Chemistry|June 17, 2006
Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activationMagdalini Rapti, Vera Knaüper, Gillian Murphy, et al.
The Journal of Biological Chemistry|January 22, 2004
Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognitionMeng-Huee Lee, Magdalini Rapti, Vera Knaüper, et al.
Plos One|August 27, 2015
Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer EffectsJing Xian Duan, Magdalini Rapti, Anastasia Tsigkou, et al.
Biochemical Society Transactions|January 28, 2020
Fragments: where are we now?James Osborne, Stanislava Panova, Magdalini Rapti, et al.
Oncotarget|February 11, 2017
Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibitionBingjie Jiang, Yan Zhang, Jian Liu, et al.
The Biochemical Journal|January 25, 2008
The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibitionMagdalini Rapti, Susan J Atkinson, Meng-Huee Lee, et al.
Cancer Letters|October 10, 2009
The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environmentMeng-Huee Lee, Susan Atkinson, Magdalini Rapti, et al.
Pageof 2